Results 141 to 150 of about 1,124 (174)

Droxidopa for the Treatment of Parkinson’s Disease

2020
Mizuki Ito, Hirohisa Watanabe
openaire   +1 more source

Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension

Clinical Autonomic Research, 2016
Ahmed Negida, MBBCh, Mohamed Gadelkarim, Ahmed Elgebaly   +2 more
exaly  

Simultaneous determination of droxidopa and carbidopa using a carbon nanotubes paste electrode

Sensors and Actuators B: Chemical, 2013
Somayeh Tajik, Hadi Beitollahi, Mohammad Ali Taher   +2 more
exaly  

Simultaneous voltammetric determination of droxidopa, acetaminophen, and tyrosine on hematoxylin and graphene oxide/ZnO nanocomposite-modified glassy carbon electrode

Ionics, 2017
Hadi Beitollahi, Mohammad R. Ganjali
exaly  

Droxidopa/levodopa/carbidopa

Reactions Weekly, 2012
openaire   +1 more source

A molecular study on drug delivery system based on carbon nanotube for the novel norepinephrine prodrug, Droxidopa

Journal of Molecular Liquids, 2019
Moslem Jahani, Mehdi Yoosefian
exaly  

Pilot Study of Droxidopa With Carbidopa in Adults With ADHD

Journal of Attention Disorders, 2019
Lenard A Adler
exaly  

Droxidopa for the Short-Term Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Parkinson's Disease (nOH306B)

Movement Disorders, 2015
L Arthur Hewitt
exaly  

Stabilisiert Droxidopa den Blutdruck?

InFo Neurologie & Psychiatrie, 2014
openaire   +1 more source

Hemodynamic effects of L-threo-3,4-dihydroxyphenylserine (Droxidopa) in hypotensive individuals with spinal cord injury.

Archives of Physical Medicine and Rehabilitation, 2013
Jill M Wecht, William A Bauman, Joseph P. Weir   +2 more
exaly